Next Article in Journal
From Normal to Obesity and Back: The Associations between Mitochondrial DNA Copy Number, Gender, and Body Mass Index
Next Article in Special Issue
Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
Previous Article in Journal
(Epi)genetic Modifications in Myogenic Stem Cells: From Novel Insights to Therapeutic Perspectives
Previous Article in Special Issue
mTOR Signalling in Head and Neck Cancer: Heads Up
Open AccessReview

mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro

Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011 Doornfontein, South Africa
Author to whom correspondence should be addressed.
Cells 2019, 8(5), 431;
Received: 31 March 2019 / Revised: 22 April 2019 / Accepted: 30 April 2019 / Published: 9 May 2019
(This article belongs to the Special Issue mTOR Signaling in Metabolism and Cancer)
The Mechanistic or Mammalian Target of Rapamycin (mTOR) is a major signaling pathway in eukaryotic cells belonging to the P13K-related kinase family of the serine/threonine protein kinase. It has been established that mTOR plays a central role in cellular processes and implicated in various cancers, diabetes, and in the aging process with very poor prognosis. Inhibition of the mTOR pathway in the cells may improve the therapeutic index in cancer treatment. Photodynamic therapy (PDT) has been established to selectively eradicate neoplasia at clearly delineated malignant lesions. This review highlights recent advances in understanding the role or regulation of mTOR in cancer therapy. It also discusses how mTOR currently contributes to cancer as well as future perspectives on targeting mTOR therapeutically in cancer in vitro. View Full-Text
Keywords: cancers; mTOR; inhibitors; photodynamic therapy cancers; mTOR; inhibitors; photodynamic therapy
Show Figures

Figure 1

MDPI and ACS Style

Ayuk, S.M.; Abrahamse, H. mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro. Cells 2019, 8, 431.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop